News stories about Avinger (NASDAQ:AVGR) have trended somewhat positive recently, Accern reports. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Avinger earned a news impact score of 0.05 on Accern’s scale. Accern also assigned headlines about the medical device company an impact score of 45.9194875814168 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Avinger (NASDAQ:AVGR) remained flat at $$0.23 during midday trading on Wednesday. The company had a trading volume of 682,200 shares, compared to its average volume of 1,168,563. Avinger has a 52-week low of $0.21 and a 52-week high of $4.55.
In other Avinger news, insider John B. Ph D. Md Simpson sold 1,074,130 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $0.25, for a total transaction of $268,532.50. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Chairman John B. Ph D. Md Simpson sold 454,584 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $0.27, for a total transaction of $122,737.68. The disclosure for this sale can be found here. Corporate insiders own 17.00% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Avinger (AVGR) Earning Somewhat Positive Media Coverage, Report Finds” was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/12/06/avinger-avgr-earning-somewhat-positive-media-coverage-report-finds.html.
Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.
Receive News & Ratings for Avinger Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger Inc. and related companies with MarketBeat.com's FREE daily email newsletter.